MD Anderson and Cyclacel Pharmaceuticals announce strategic alliance to study novel Cyclacel medicin
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that ...










